|1.||WO||WO/2014/170906 - A NOVEL HAIR GRAFT IMPLANTER||23.10.2014||
|PCT/IN2013/000341||ATODARIA, Pradipkumar Raghuvirsinh||ATODARIA, Pradipkumar Raghuvirsinh|
The present invention relates to a novel implanter for hair graft implantation. In particular, the present invention relates to a manually operated implanter which implants a single hair grafts in a curvilinear track with significantly reduced pop-out of the nearby implanted hair grafts.
|2.||WO||WO/2014/170907 - AN ENERGY EFFICIENT PRESSURE LESS STEAM GENERATOR||23.10.2014||
||PCT/IN2013/000434||VEMPATI Venkata Sundereswar Rao||VEMPATI Venkata Sundereswar Rao|
An energy efficient electrically operated steam generator is capable of producing pressure less high temperature as well as superheated steam. It comprise of main body (14) defined by side wall, roof (2) and open bottom, securely fixed to the rim of water holding tray (7). Said roof is provided with steam outlet nozzles (16) to allow the steam to emerge out of the steam generator. A porous ceramic honeycomb (3) with plurality of parallel channels (4), and grooves (5) or holes (23) are created therein for inserting heating element (6). One end of all the channels (4) is always submerged in water (11 ) in tray (7), and the other end of most of the channels is open to the roof and both ends of the heating element are connected to the power source for heating the water to generate steam.
|3.||WO||WO/2014/170915 - INSECT REPELLENTS||23.10.2014||
|PCT/IN2014/000244||COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH||REDDY, Dumbala Srinivasa|
Disclosed herein are the novel insect repellents of formula (I) to control the spread of various tropical diseases and to the process of preparation thereof wherein R, Rl, R3, R4 represents hydrogen or alkyl; R2 is selected from hydrogen, alkyl, C02R, C02H; 'n' is 1, 2, or 3; wherein any two of Rl, R2, R3 or R4 may form a 3-8 membered carbocyclic ring which may optionally be substituted or may contain a heteroatom; X is selected from O, S or CH2; ' ' represents a single or double bond; wherein, either of the ring in formula (I) may additionally contain at least one carbonyl group.
|4.||WO||WO/2014/170918 - A NOVEL MEDICAL EQUIPMENT FOR ANCHORING AND CLOSING OF CRANIAL FLAP DURING NEUROSURGERY OF HEAD AT CUT LINES||23.10.2014||
|PCT/IN2014/000255||AGARWAL GHANSHAM DAS||AGARWAL GHANSHAM DAS|
This invention relates to a novel medical equipment for anchoring and closing of cranial flap during neurosurgery of head at cut lines comprising of atleast two discs connected by means of a connecting member, wherein the top and bottom disc is provided with a cut on the same side. It is associated with the following advantageous features: - Fast to use and apply i.e. less than two minutes. - Cost effective. - No requirement of any special instrumentation for application. - Prevention of damage to brain by resisting pressure. - Fast re-opening of craniotomy flap without requiring special instrumentation. - Reasonable. - Allows outward movement of cranial flap in case of brain edema.
|5.||WO||WO/2014/170917 - DESIGNER CELLS FOR ENANTIOSELECTIVE REDUCTION OF KETONES AND USE THEREOF IN EFFICIENT PRODUCTION OF ENANTIOENRICHED ALCOHOLS||23.10.2014||
|PCT/IN2014/000247||COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH||SRIVASTAVA, Gautam|
The present invention is to provide a preparation of variant recombinant whole cell biocatalysts, referred herein as "designer cells" having significantly enhanced carbonyl reductase activity for use in the efficient production of variant industrially important enantiomerically enriched alcohols. More specifically, the alcohol is optically pure ethyl (S)-4-chloro-3-hydroxybutyrate, which is useful as chiral building block and an intermediate for the production of hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors.
|6.||WO||WO/2014/170914 - ROHITUKINE ANALOGS AS CYCLIN-DEPENDENT KINASE INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF||23.10.2014||
|PCT/IN2014/000239||COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH||VISHWAKARMA, Ram Asrey|
The present invention relates to the rohitukine (5,7-dihydroxy-8-(3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-ones) analogs of formula A and pharmaceutically acceptable salts thereof. In addition, the invention relates to pharmaceutically acceptable compositions comprising at least one such compound, and methods of using the compounds for treating or preventing various proliferative disorders such as melanoma, leukemia, breast cancer and prostate cancer etc. [insert Formula A here] wherein, n=0 or 1, when n=1, the dotted line indicates the double bond.
|7.||WO||WO/2014/170916 - NOVEL URICASE MUTANTS||23.10.2014||
|PCT/IN2014/000246||COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH||PRASAD, Gandham Satyanarayana|
The present invention relates to the uricase mutant and use thereof. More particularly, the present invention relates to mutant uricase, its production and to a recombinant peptide sequence and its corresponding recombinant nucleotide sequence.
|8.||WO||WO/2014/170912 - ALL-SOLID-STATE-SUPERCAPACITOR AND A PROCESS FOR THE FABRICATION THEREOF||23.10.2014||
|PCT/IN2014/000233||COUNCIL OF SCIENTIFIC & INDUSTRIAL RESSEARCH||KURUNGOT, Sreekumar|
The present invention discloses. all-solid-state supercapacitor (ASSP) with enhanced electrode-electrolyte interface which gives highest very high specific capacitance, areal capacitance and shows very low internal resistance (ESR). The invention particularly discloses the fabrication of all-solid-state supercapacitor by intercalation of solid state polymer electrolyte inside the conducting porous substrate coated with a charge storage electrode material to achieve the desired effect.
|9.||WO||WO/2014/170910 - PROCESS FOR THE PREPARATION OF LAPATINIB||23.10.2014||
|PCT/IN2014/000210||NATCO PHARMA LIMITED||MUDDASANI, Pulla Reddy|
Present process relates to an improved and commercial process for the preparation of lapatinib of formula-I or its pharmaceutically acceptable p-toluenesulfonate salt involving novel intermediates of formulae-XVII, XVIII, and XIX. Present process utilizes Meerwein reaction as a key step in the aryl C-C bond formation step avoiding costly boronate coupling chemistry used in the conventional synthesis of lapatinib.
|10.||WO||WO/2014/170909 - PROCESS FOR POMALIDOMIDE||23.10.2014||
|PCT/IN2014/000205||HETERO RESEARCH FOUNDATION||PARTHASARADHI REDDY, Bandi|
The present invention provides a novel process for the preparation of pomalidomide crystalline Form I. The present invention also provides a process for the purification of pomalidomide.